Liquidia Corporation Common Stock vs Nomura Holdings Inc — how do they compare? Liquidia Corporation Common Stock trades at $33.78 (market cap $2.40B), while Nomura Holdings Inc trades at $9.2 (market cap $28.01B). The key difference: Nomura Holdings Inc is far larger — about 11.7× Liquidia Corporation Common Stock's market cap, and Nomura Holdings Inc pays a 3.38% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Nomura Holdings Inc for 56 Days on average.
| LQDA | NMR | |
|---|---|---|
Market Cap | $2.40B | $28.01B |
Volume | 2,857,547 | 686,801 |
Sector | Health | Financials |
52-Week High | $91.03 | $10.86 |
52-Week Low | $22.02 | $6.92 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $2.30B | $38.48T |
Dividend Yield | — | 3.38% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nomura Holdings (NMR) trades at $9.26, down 3.24% with bearish technical signals. The stock shows mixed earnings performance with recent misses but strong revenue growth from $1.66T in 2025. Valuation appears attractive with P/E of 11.37 and P/B of 1.16, while analyst sentiment leans cautious with 67% hold ratings. Recent Zacks coverage highlights momentum potential and hammer chart pattern formation.
Outlook remains balanced with fundamental strength in profitability margins (20.4% net income) offset by technical weakness. Investment opportunity lies in discounted valuation amid earnings growth, while risks include cash flow volatility and rising debt levels. The stock requires careful monitoring of Q3 2026 earnings results for directional clarity.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →